Bivalent COVID-19 booster elicits a stronger response than the original vaccine, Pfizer says
Pfizer and BioNTech said Friday that their bivalent COVID-19 booster, which targets the original strain of SARS-CoV-2 and the omicron BA.4 and BA.5 sublineages, elicits stronger immune responses than their original vaccine.
Adults aged 18 to 55 years experienced a 9.5-fold increase in neutralizing antibody titers against the omicron sublineages compared with pre-booster levels, and people older than 55 years saw a 13.2-fold rise, according to data reported in a press release.
In adults aged older than 55 years, neutralizing antibodies were fourfold higher after receiving the bivalent booster
Uber And Lyft Will Give Free Rides To COVID-19 Vaccination Spots, White House Says
Lyft will offer up to $15 for trips to or from a vaccination site. The deal covers daytime rides on bikes and scooters, as well as in cars. (Image…
Do vitamin D, zinc, and other supplements help prevent COVID-19 or hasten healing?
The appeal of safe, natural treatments is undeniable. It’s true for age-old conditions such as the common cold, and for new diseases, especially if they have no known cure. So…
Denmark Extends Its Suspension of the AstraZeneca Vaccine
Officials want to investigate whether the vaccine is related to blood clots and other rare but dangerous problems. Denmark will extend its suspension of the AstraZeneca vaccine until April 15,…
CDC Says It’s Safe For Vaccinated People To Do These Activities
The Centers for Disease Control and Prevention has issued new guidance for vaccinated people, giving the green light to resume some pre-pandemic activities and relax precautions that have been in…
Data Show India’s Homegrown COVID-19 Vaccine Works — 2 Months After It Was Approved
It turns out a COVID-19 vaccine that stirred controversy in India may be effective after all. The Indian government approved the use of the COVAXIN vaccine, made by the Indian company Bharat…
Grandparents and vaccines: Now what?
As COVID-19 vaccines roll out across the US, many grandparents — including one co-author of this blog post — are thrilled to hold out their arms for a jab. In…
Touchless in Covid’s time
It seems quite that after 2020, companies and their employees will survive 2021 in virtual reality. With what experiences does LSK Hungária Kft. Look behind it for the period ahead…
Covid trial in UK examines mixing different vaccines
Giving different first and second jabs could offer more flexibility and may offer better protection. A UK Covid trial has been launched to see if giving people different Covid vaccines…
Johnson & Johnson Applies For Emergency Use Authorization For COVID-19 Vaccine
The company’s vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines…